Already a versatile molecule, a custom peptideis modified for all-new purposes with bioconjugation.

Peptide conjugation is an effective research tool, with applications in antibody development, affinity purification, cell transport, and pharmacology. 

Crosslinkers

Common peptide bioconjugationsutilise the side chain of a lysine or cysteine residue present in the sequence to bind to other molecules, such as proteins, antibodies, or oligonucleotides.

Mimotopes’ custom peptide conjugations maximise product efficacy with a variety of linkers, such as amines and sulfhydryls.

Find out more 

Conjugations

Special bioconjugations and Click Chemistry are well known for their versatility.

Conjugation with fluorophores allows for fluorescent response. Pegylation, conjugation to PEGs, aids in biological functionality. From biotin to PMOs, the list of potential conjugations is endless. 

Conjugation to Other Peptides

For a custom peptide designed to operate within a cell, crossing the cell membrane is often a challenge.

Conjugating to a peptide already capable of entering the cell forms a heterodimer, retaining this function. Once in position, the peptides can divest their bond, freeing the customised peptide to fulfil its purpose.

Gel Conjugation

As a highly-specific selection technique, affinity chromatography relies on peptide conjugation.

To produce a pure anti-peptide antibody serum, the peptide is conjugated to an immobilised gel in a column. The antibodies and buffer solution wash through, ensuring only the highest affinity antibodies bind to the conjugated peptides.

Antibody Conjugation

Conjugation of a peptide antigen to an immunogenic carrier protein is crucial for anti-peptide antibody generation.

In one method, a cysteine residue in the peptide can be linked to a maleimide group on the chosen protein to form a stable thioether bond between them.

Find out more 

Contact us today for a conjugated peptide quote 

Phone: +61 3 9565 1111
Fax: +61 3 9565 1199 
Email: mimotopes@mimotopes.com

Australia

Phone: +61 3 9565 1111

Email: australia@mimotopes.com

North and South America

Phone: +1 651 603 0909

Email: useast@mimotopes.com
uswest@mimotopes.com

Asia

Phone: +61 3 9565 1111
Email: asia@mimotopes.com

UK / Europe / Africa / Middle East

Phone: +44 (0)151 556 0547

Email: europe@mimotopes.com

Go to article: Home | The path of yeast resistanceGo to article: NSFGo to article: EditorialGo to article: ContentsGo to article: NewsGo to article: Emirates SkyCargoGo to article: The pharma industry briefingGo to article: A resolution for the new decade: resolve the US opioid crisisGo to article: Eurofins CDMOGo to article: Precision medicine: what barriers remain?Go to article: Can recyclable packaging turn the pharma industry green?Go to article: Phoenix Company InsightGo to article: PhoenixGo to article: Vertex’s Trikafta: treating the genetic basis of cystic fibrosis Go to article: Accurate Biometrics Company Insight Go to article: Accurate BiometricsGo to article: Q&A: talking innovation with the Association for the Cannabinoid IndustryGo to article: Yeast of burden: how to develop better antifungal drugsGo to article: Loose lips bring risks: protecting pharma against leaks and fraud Go to article: Why are patients struggling to access life-saving immune globulin?Go to article: MimotopesGo to article: Deals in brief powered by GlobalDataGo to article: Nolato Company Insight Go to article: NolatoGo to article: The key list powered by GlobalDataGo to article: EventsGo to article: Next issue